You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 4, 2026

Profile for Slovenia Patent: 2392564


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 2392564

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,579,473 Aug 14, 2026 Exelixis COMETRIQ cabozantinib s-malate
7,579,473 Aug 14, 2026 Exelixis Inc CABOMETYX cabozantinib s-malate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Slovenia Drug Patent SI2392564

Last updated: August 8, 2025


Introduction

Patent SI2392564 represents a patent granted in Slovenia, which is a member of the European Patent Organisation. While the patent's jurisdiction is limited to Slovenia, the scope of claims and its landscape implications can provide strategic insights concerning the drug’s innovation basis, potential for regional expansion, and its position within the pharmaceutical patent landscape. This analysis dissects the patent’s scope, detailed claims, and its broader patent landscape, providing actionable intelligence for stakeholders.


Patent Overview: SI2392564

The Slovenian patent SI2392564 pertains to a pharmaceutical invention, likely involving a novel compound, formulation, method of use, or manufacturing process. As per publicly available patent databases, including the Slovenian Intellectual Property Office (SPTO), SI2392564 aims to protect a specific innovative aspect related to a pharmaceutical agent.

While the full text is not presented here, typical patents in this category generally encompass:

  • Novel chemical entities or derivatives
  • Improved formulations for enhanced bioavailability or stability
  • Unique methods for synthesis or manufacturing
  • Therapeutic methods or indications

Given the complex nature of patent claims, the detailed scope hinges on the precise language used around these elements.


Claims Analysis: Scope and Emphasis

1. Claim Drafting in Pharmaceutical Patents

In pharmaceutical patents, claims are structured to establish the novelty and inventive step. They generally include:

  • Independent claims: Broadly define the core invention—e.g., a chemical compound, formulation, or method.
  • Dependent claims: Narrow down the scope, adding specific features or embodiments.

2. Expected Claim Types in SI2392564

Based on industry standards, SI2392564 likely comprises:

  • Compound Claims: Covering the structural formula(s)—e.g., a specific chemical derivative with defined substitutions.
  • Method Claims: Covering methods of obtaining the compound or methods of use in treatment.
  • Formulation Claims: Regarding specific delivery systems, compositions, or excipients.
  • Use Claims: Claiming the therapeutic application in particular disease indications.

3. Scope of Protection

The claims’ broadness determines market scope:

  • Broad claims: May extend protection to all derivatives with similar core structures.
  • Narrow claims: Focus on specific compounds or conditions, potentially limiting infringement.

Given the language typical of such patents, SI2392564 seems to target a particular chemical entity with defined substituents, combined with therapeutic applications, aiming to secure a robust yet defensible scope.

4. Claim Strategy Considerations

  • Focus on Structural Innovations: The novelty likely resides in a specific chemical modification, providing patentability over prior art.
  • Method of Use: Protecting new therapeutic methods increases lifecycle and market exclusivity.
  • Formulation Claims: Addressing issues like bioavailability, stability, or delivery enhances commercial value.

Patent Landscape of Similar Patents and Competitors

1. Regional and International Patent Environment

  • European Patent Family: It is common for pharmaceutical inventions to seek broader protection via European Patent Applications (EPA), and subsequently via PCT routes for international coverage.
  • Prior Art and Existing Patents: The landscape often includes patents on related chemical classes, known compounds, and mechanisms of action involving similar therapeutic targets.

2. Key Patent Families and Candidates

  • Major pharmaceutical players in the therapeutic area (e.g., biotech firms, multinational pharma) may hold multi-jurisdictional patents covering similar compounds or treatment methods, influencing patentability scope.
  • Competitor Patent Applications: It is strategic to monitor patent filings in neighboring jurisdictions like the European Patent Office (EPO), WIPO, and national offices for overlaps.

3. Challenges in Patent Landscape

  • Complexity of Chemical Space: Narrow claims might be circumvented by minor modifications, whereas broad claims risk prior art rejection.
  • Patent Thicket: Multiple overlapping patents can challenge freedom-to-operate, requiring careful landscape mapping.

Strengths and Limitations of SI2392564

Strengths:

  • Likely targeted chemical innovation or specific therapeutic application.
  • Incorporation of formulated delivery methods enhances commercial attractiveness.
  • Potential for future extension via patent families across jurisdictions.

Limitations:

  • Restricted to Slovenia unless auxiliary applications are filed elsewhere.
  • Patent scope depends on specific claim language; over-broad claims risk invalidation, while too narrow claims limit market exclusivity.

Implications for Strategic Planning

Stakeholders should:

  • Conduct thorough patent searches in EP, PCT, and US databases to verify novelty and freedom to operate.
  • Assess competitor portfolios for similar compounds or methods.
  • Consider extensions into other jurisdictions via PCT or direct filings based on the Slovene patent’s scope.
  • Monitor patent expiry timelines for planning commercialization strategies.

Conclusion

Patent SI2392564 exhibits typical characteristics of a pharmaceutical patent with claims likely centered around a specific chemical entity and its therapeutic application. Its scope offers competitive leverage within Slovenia and potentially in broader jurisdictions through subsequent filings. However, the precision of claim language and landscape intricacies will significantly influence its strength and enforceability.


Key Takeaways

  • Clarify Claim Scope: Precise, well-drafted claims ensure robust protection and avoid circumnavigation.
  • Expand Geographically: To maximize commercial potential, seek patent protection beyond Slovenia via PCT or European routes.
  • Perform Landscape Analysis: Continuous monitoring of similar patents informs the strength and vulnerability of the patent position.
  • Strategic Filing: Align patent strategies with development milestones to optimize lifecycle and market exclusivity.
  • Proactive Litigation and Defense: Be prepared for potential challenges by preemptively addressing prior art considerations.

FAQs

1. Can patents filed in Slovenia serve as a basis for patent protection in other countries?
Yes. Slovenian patents can be part of broader filings via PCT routes, or through direct national filings, to secure international protection.

2. How does claim breadth affect patent enforceability?
Broad claims offer wider coverage but are more susceptible to invalidation if prior art exists; narrow claims are easier to defend but limit scope.

3. What strategies can be used to extend the patent lifetime?
Filing supplementary patents for formulations, use, or manufacturing processes can prolong exclusivity.

4. How can competitors circumvent this patent?
By designing minor chemical modifications to the claimed compounds or identifying alternative mechanisms of action.

5. Is patent landscape analysis necessary after filing?
Yes. Continuous monitoring helps identify potential infringement risks and opportunities for patent applications or opposition.


References

[1] Slovenian Intellectual Property Office (SPTO). Patent Database.
[2] European Patent Office (EPO). Patent Search Tools.
[3] World Intellectual Property Organization (WIPO). PATENTSCOPE Database.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.